TOKYO – Japan has asked Swiss pharmaceutical organization Roche and other corporations to increase production of antigen verification kits that can detect COVID-19 infection and seasonal influenza.
In reaction to demand, corporations are taking steps to manufacture 35 to 40 million doses by this winter, according to a government official, as a simultaneous outbreak of COVID and flu is expected.